Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Notice of Intent - Twist Bioscience

U.S. Department Of Justice·District of Columbia

Notice of Intent - Twist Bioscience

Closes 4/29/2026$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Federal Bureau of Investigation (FBI) is issuing a notice of intent to procure a custom panel from Twist Bioscience. The panel is required for the continued development of the Investigative Genetic Genealogy workflow and to properly and efficiently process and analyze DNA samples submitted to the FBI Laboratory. The custom panel is a specific product that is commercially available but has been extensively tested and validated by the FBI Laboratory and its contract labs. The FBI intends to negotiate with only one source, Twist Bioscience, under the authority of FAR 6.302-1. Interested parties may identify their interests and capability to respond to this requirement by 5:00 PM (EST) on 29 April 2026. • The custom panel is a critical component of the FBI Laboratory's operations. • The panel is required for the continued development of the Investigative Genetic Genealogy workflow. • The FBI has already extensively tested and validated the custom panel. • The custom panel is a specific product that is commercially available but has no authorized resellers.

Attached files

Contact

Jonathan Johnson

[email protected]

Key dates

Opened
4/22/2026
Questions due
4/29/2026
Closes
4/29/2026
Duration
120 days

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
334516
Solicitation №
NOI001542

Budget estimate

$100,000 – $500,000

The budget for this opportunity is likely to be in the range of $100,000 to $500,000. This estimate is based on the fact that the custom panel is a specific product used in laboratory operations and the FBI has already extensively tested and validated the product. The budget may be influenced by the complexity of the custom panel, the quantity required, and the negotiations with Twist Bioscience.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Defense·Maryland

Top match · 69%

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

University of South Carolina·South Carolina

66% match

Notice Of Intent To Sole Source – University of South Carolina Collaborative ALS Research Services

Rolling / TBD closeOpened 10/5/2026

U.S. National Science Foundation·United States of America

64% match

A Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO)

Closes 2/9/2027Opened 3/21/2023

U.S. National Institutes of Health·United States of America

63% match

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Closes 9/7/2027Opened 3/8/2022

U.S. National Institutes of Health·United States of America

63% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Science Foundation·United States of America

62% match

Core Research in Biological Sciences (BIO Core)

Closes 10/5/2076Opened 8/17/2026

Department of Public Health·South Carolina

61% match

Notice Of Intent To Sole Source By: Department of Public Health

Rolling / TBD closeOpened 10/1/2026

U.S. National Institutes of Health·United States of America

61% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

61% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. National Institutes of Health·United States of America

61% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

61% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Energy·Ohio

61% match

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Closes 3/22/2027Opened 9/22/2026

U.S. National Institutes of Health·United States of America

60% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

60% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

60% match

Notice of Intent: Program to End Modern Slavery FY 2023

Rolling / TBD closeOpened 1/20/2023

U.S. Department Of Health And Human Services·Maryland

60% match

Notice of Intent to Sole Source: Peer-to-peer Immunization Training and Curriculum Deployment

Closes 11/6/2026Opened 10/23/2026

U.S. Department Of Energy·Ohio

60% match

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

Closes 12/5/2026Opened 6/5/2026

Michigan Department of Health and Human Services Procurement Office·Michigan

60% match

Notice of intent to award ITN 270000000002

Closes 11/2/2026Opened 10/29/2026

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

60% match

Notice of Intent: Program to End Modern Slavery FY 2025

Rolling / TBD closeOpened 12/2/2024

U.S. National Institutes of Health·United States of America

60% match

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Closes 6/2/2027Opened 6/17/2024

U.S. National Institutes of Health·United States of America

60% match

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Closes 6/15/2027Opened 10/23/2024

U.S. National Institutes of Health·United States of America

60% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

60% match

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Closes 6/2/2027Opened 6/17/2024

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

60% match

Notice of Intent: Program to End Modern Slavery FY 2022

Rolling / TBD closeOpened 1/21/2022

U.S. National Institutes of Health·United States of America

60% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024